FDA Inspection 1018407 — Bella Pharmaceuticals, Inc.
The FDA completed an inspection of Bella Pharmaceuticals, Inc. on July 18, 2017 in Glenview, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 18, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Glenview, IL (United States)